Sunday, March 22, 2020

CHLOROQUINE DOES TREAT COVID-19. IT WAS USED TO TREAT SARS IN 2009



CHLOROQUINE  IS SAVING LIVES. 



USA TODAY: APRIL 8, 2020
"Democratic Michigan state Rep. Karen Whitsett gave a testimonial about her experience with COVID-19 and hydroxychloroquine on national television.
Within a few hours of taking the drug, she said she was already in recovery.
While the representative acknowledges that there is no way to verify whether her recovery from COVID-19 was entirely due to the drug without further research, she credits Trump and the anti-malarial treatment for saving her. We rate this claim TRUE because it is supported by our research."



March 23, 2020
"I Was on the Brink of Death and Malaria Drug Saved My Life"


"A Florida man who contracted the coronavirus is crediting his survival with the anti-malaria drug hydroxychloroquine.
Giardinieri, who is 52, recalled falling so ill that he said goodbye to his family, as doctors put him on oxygen and told him there was nothing more they could do for him as he battled the virus.
Rio Giardinieri told KTTV-TV that doctors gave the drug to him Friday while he was in critical condition diagnosed with coronavirus and pneumonia at Joe DiMaggio Children’s Hospital in Hollywood, Florida.
“It allowed me to go to sleep and when I woke up at exactly 4:45 in the morning, I woke up like nothing ever happened,” he said.

Despite reported cases of success in using drugs such as chloroquine to combat COVID-19, Trump has been criticized for being optimistic about their potential.

New York Gov. Andrew Cuomo, a Democrat who announced his state will begin trials on the drug Tuesday, has not faced the same criticism.

Forbes reported New York, which is a hotspot for U.S. cases of coronavirus, has acquired 750,000 doses of chloroquine, 70,000 doses of hydroxychloroquine and 10,000 doses of the antibiotic Zithromax." 

--Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialConclusion
Available online 20 March 2020
CONCLUSION
"Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19 patients and its effect is reinforced by azithromycin."

--Preliminary trials of chloroquine repurposing in the treatment of COVID-19 in China have been encouraging, leading to several new trials. Here we discuss the possible mechanisms of chloroquine interference with the SARS-CoV-2 replication cycle.

Conclusion
Chloroquine has been shown to be capable of inhibiting the in vitro replication of several coronaviruses. Recent publications support the hypothesis that chloroquine can improve the clinical outcome of patients infected by SARS-CoV-2



SIMILAR RESULTS HAVE BEEN WRITTEN IN MEDICAL JOURNALS, NEWS HEADLINES, SOCIAL MEDIA "TESTIMONIALS", ETC, FROM MANY NATIONS AROUND THE WORLD, BUT THE MAINSTREAM MEDIA AND LEFT-WING TRUMP-HATERS HERE ARE ALWAYS GOING TO TWIST, SPIN AND LIE ABOUT THESE RESULTS.
I BELIEVE THEY'D RATHER SEE PATIENTS DEPRIVED OF LIFE-SAVING DRUG THERAPIES THAN SEE TRUMP CREDITED WITH ANYTHING POSITIVE.
THIS MAKES THEM MONSTERS IN THE EYES OF MILLIONS.

AMERICAN MAINSTREAM MEDIA REFUSES TO WRITE ABUT RECOVERIES, ABOUT EFFECTIVE TREATMENTS, ABOUT HUMAN BEINGS WHO ARE ALIVE BECAUSE A DRUG TRUMP SUPPORTED THE USE OF ACTUALLY SAVED LIVES. 


U.S. UPDATE AS OF SUNDAY, MARCH 22, 2020: 

ACCORDING TO THE JOHNS HOPKINS WEBSITE, 35,211 cases of the virus have been confirmed in the U.S., leading to at least 471 deaths as of Sunday morning.

(1.3% "DEATH RATE") 

HOW MANY OF THOSE DEATHS WERE ELDERLY PATIENTS (OR OTHERS) WITH PRE-EXISTING MEDICAL CONDITIONS WE MAY NEVER KNOW.

I HAVE NOTICED OTHER NATIONS COUNTING THOSE WHO DIED OF CARDIAC ARREST DURING THEIR ILLNESS ATTRIBUTING THE DEATHS TO COVID-19.


U.S. CDC research shows that chloroquine has strong potential as a prophylactic (preventative) measure against coronavirus in the lab.

Chloroquine is an inexpensive, globally available drug that has been in widespread human use since 1945 against malaria, autoimmune and various other conditions.



The CDC has also reported in a peer-reviewed article in Virology Journal that according to its own research,

“…chloroquine has strong antiviral effects on SARS coronavirus, both prophylactically and therapeutically. SARS coronavirus has significant similarities to COVID-19.

 Specifically, the CDC research was completed in primate cells using chloroquine’s well known function of elevating endosomal pH. The results show that “We have identified chloroquine as an effective antiviral agent for SARS-CoV in cell culture conditions, as evidenced by its inhibitory effect when the drug was added prior to infection or after the initiation and establishment of infection.

The fact that chloroquine exerts an antiviral effect during pre- and post-infection conditions suggest that it is likely to have both prophylactic and therapeutic advantages.”

The study shows that chloroquine is effective in preventing SARS-CoV infection in cell culture if the drug is added to the cells 24 h prior to infection."

FORBES QUIETLY UPDATED THEIR ARTICLE ON TRUMP'S STATEMENTS March 19, 2020 

"President Trump said in a Thursday press briefing that chloroquine and hydroxychloroquine, drugs used to treat malaria and severe arthritis, were approved by the Food and Drug Administration to test as a COVID-19 coronavirus treatment, as the number of cases nationwide continues to increase.

The drugs WILL be used in a clinical trial, according to FDA commissioner Dr. Stephen Hahn, who spoke during the press briefing.

Key background: The medical journal Clinical Infectious Diseases reported March 9 that Plaquenil, the brand-name version of hydroxychloroquine, was effective in killing the coronavirus in laboratory experiments." 

WHAT FORBES AND ALL OTHER MSM FAIL TO REPORT IS THAT THIS DRUG HAS A LONG HISTORY OF USE AGAINST VIRAL AGENTS.


FROM National Center for Biotechnology Information;
U.S. National Library of Medicine 

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.


FROM PEOPLE MAGAZINE, March 19, 2020: 
 

“There is evidence that chloroquine is effective when they looked at SARS in vitro with primate cells,” said Dr. Len Horovitz, a pulmonologist and internist at Lenox Hill Hospital in New York City, told ABC News. “… In vitro in these primate cells, there was evidence that viral particles were significantly reduced when chloroquine was used.”


TESTED IN HUMANS, READILY AVAILABLE WORLDWIDE, SAFE FOR CHILDREN, ELDERLY, PREGNANT WOMEN, AND INEXPENSIVE.

BUT LOOK AT THE NAY-SAYERS IN THE 'MEDICAL PROFESSION'!
THEY MUST NOT WANT AN END TO THIS (POTENTIALLY PROFITABLE) PANDEMIC.

LET'S LOOK AT WHERE THIS DRUG HAS HELPED PATIENTS RECOVER FASTER, HAVE MILDER CASES, AND MAY EVEN BE SEEN AS A PROPHYLACTIC (PREVENTING INFECTION).

THIS EFFECT HAD PREVIOUSLY BEEN SEEN AND TESTED AS FAR BACK AS 2001:

Savarino A; Boelaert JR; Cassone A; Majori G; Cauda R.:
"Effects of chloroquine on viral infections: an old drug against today's diseases?"
-- Lancet Infect Dis. 2003; 3:722-727.


"Chloroquine exerts direct antiviral effects, inhibiting pH-dependent steps of the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses.
Its best-studied effects are those against HIV replication, which are being tested in clinical trials.
Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of tumour necrosis factor α and interleukin 6, which mediate the inflammatory complications of several viral diseases.
We review the available information on the effects of chloroquine on viral infections, raising the question of whether this old drug may experience a revival in the clinical management of viral diseases such as AIDS and severe acute respiratory syndrome (SARS), which afflict mankind in the era of globalisation."       

PREVIOUS STUDY, 2001   

Savarino A ;
Gennero L;
Sperber K
Boelaert JR;
"The anti-HIV-1 activity of chloroquine."Journal of Clinical Virology. 2001; 20: 131-135


ON THE PRESTIGIOUS LANCET WEBSITE ARE MANY OTHER REFERENCES FOR SUCH TESTS.
 CLICK HERE AND GO GET SOME.

SOME DATE BACK TO THE 1990s.

Recent guidelines from South Korea and China report that chloroquine is an effective antiviral therapeutic treatment against Coronavirus Disease 2019.

 Use of chloroquine (tablets) is showing favorable outcomes in humans infected with Coronavirus including faster time to recovery and shorter hospital stay. US CDC research shows that chloroquine also has strong potential as a prophylactic (preventative) measure against coronavirus in the lab, while we wait for a vaccine to be developed.

 Chloroquine is an inexpensive, globally available drug that has been in widespread human use since 1945 against malaria, autoimmune and various other conditions.



RECENT TESTS AND POSITIVE RESULTS

1-- CHINA    Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model.
--Cell Res. 2013; 23:300-302.


LAST YEAR, 2019.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G.;
"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro."-- Cell Res. 2020.


ABC NEWS, MAR. 19, 2019.

"Both the virus that causes SARS and the virus responsible for COVID-19 belong to the same overarching family of coronaviruses. Researchers in China discovered that the protein spikes on the surface of the COVID-19 virus are similar to the protein spikes found on the surface of the SARS virus."

Researchers in China found that treating patients with COVID-19-associated pneumonia with chloroquine may shorten their hospital stay and improve the patient’s outcome.

There are more than 20 ongoing clinical trials in China and more scheduled to start in England, Thailand, South Korea and the United States.
2-- FRANCE   
Successful COVID-19 Drug Trial by Professor in France

A renowned research professor in France has reported successful results from a new drug for COVID-19, with early trial suggesting it can stop the virus from being contagious in just six days.

Professor Didier Raoult from infection hospital l’Institut Hospitalo-Universitaire (IHU) Méditerranée Infection in Marseille (Bouches-du-Rhône, Provence-Alpes-Côte d’Azur), published a video explaining the trials on Monday, according to the Connexion.

Professor Raoult is an infectious disease specialist and head of the IHU Méditerranée Infection, who has been tasked by – and consulted by – the French government to research possible treatments of COVID-19.

He said that the first COVID-19 patients he had treated with the drug chloroquine had seen a rapid and effective speeding up of their healing process, and a sharp decrease in the amount of time they remained contagious.


Chloroquine – which is normally used mainly to prevent and treat malaria – was administered via the named drug, Plaquenil.

The treatment was offered to 24 patients, who were among the first to become infected in the southeast of France, and who had voluntarily admitted themselves to hospital for the process.

Patients were given 600mcg per day for 10 days. They were closely monitored, as the drug can interact with other medication, and cause severe side effects in some cases.

Chloroquine phosphate and hydroxychloroquine have previously been used to treat coronavirus patients in China, in ongoing COVID-19 clinical trials.

A new academic study, published on Friday by US scientific researchers, also said that chloroquine appeared to be an effective treatment, and appears to align with the findings in France.


It said, “Use of chloroquine (tablets) is showing favorable outcomes in humans infected with Coronavirus including faster time to recovery and shorter hospital stay…

“Research shows that chloroquine also has strong potential as a prophylactic (preventative) measure against coronavirus in the lab, while we wait for a vaccine to be developed.

“Chloroquine is an inexpensive, globally available drug that has been in widespread human use since 1945 against malaria, autoimmune and various other conditions…(it) can be prescribed to adults and children of all ages.

“It can also be safely taken by pregnant women and nursing mothers (
and) has been widely used to treat human diseases, such as malaria, amoebiosis, HIV, and autoimmune diseases, without significant detrimental side effects.”         
3-- ISRAEL

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the U.S. to meet the urgent demand for the medicine as an investigational target to treat COVID-19.
The company is also looking at additional ways to address the global need.

Hydroxychloroquine sulfate tablets manufactured by Teva are approved by U.S. Food and Drug Administration (FDA) for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.

Although the product is not currently approved for use in the treatment of COVID-19, it is currently under investigation for efficacy against the coronavirus and has been requested by US government officials to be made available for use immediately.

The Company is also reviewing supply of both hydroxychloroquine and chloroquine globally to determine whether there are additional supply and access opportunities for patients.


4-- SOUTH KOREA

According to the Korea Biomedical Review, in February, the COVID-19 Central Clinical Task Force agreed to treatment principles for coronavirus patients.

"Antimalarial Drug Chloroquine Shows Promise in Treating COVID-19 Coronavirus in China, South Korea"


5-- UNITED STATES
Judith James, M.D., Ph.D., vice president of Clinical Affairs at OMRF, says that she has found chloroquine phosphate highly effective in treating patients with lupus, an autoimmune disease, and explains how the drug may work in people with COVID-19.   

“When malaria gets into a cell, if you change the pH with a drug like chloroquine phosphate, the malaria can’t live,” she says, according to Oklahoma TV station KFOR. “The same goes for a virus like COVID-19.
If you change the pH, the virus cannot assemble, and if can’t assemble, it can’t affect you.”

“That would be really exciting, because it’s a drug that already has FDA approval, and it is readily available,” she says. “If it works, it might treat COVID-19 almost instantly.


Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah and Stuart T Nichol.
--Published: 22 August 2005 in Virology Journal  2:69 doi:10.1186/1743-422X-2-69


In the journal Nature, ‘Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro’ 

[Click on the underlined numbers to go to those reference links]


"Chloroquine, a widely-used anti-malarial and autoimmune disease drug, has recently been reported as a potential broad-spectrum antiviral drug. 89

Chloroquine is known to block virus infection by increasing endosomal pH required for virus/cell fusion, as well as interfering with the glycosylation of cellular receptors of SARS-CoV. 10 

Our time-of-addition assay demonstrated that chloroquine functioned at both entry, and at post-entry stages of the 2019-nCoV infection in Vero E6 cells (Fig. 1c, d).

Besides its antiviral activity, chloroquine has an immune-modulating activity, which may synergistically enhance its antiviral effect in vivo. Chloroquine is widely distributed in the whole body, including lung, after oral administration.

The EC90 value of chloroquine against the 2019-nCoV in Vero E6 cells was 6.90 μM, which can be clinically achievable as demonstrated in the plasma of rheumatoid arthritis patients who received 500 mg administration. 11 

Chloroquine is a cheap and a safe drug that has been used for more than 70 years and, therefore, it is potentially clinically applicable against the 2019-nCoV. "  IT IS MERELY LOGICAL AND SANE TO TRY OLDER DRUGS IN NEW WAYS ON THIS NEW VIRUS, ESPECIALLY GIVEN THAT CHLROQUINE HAS BEEN USED BEFORE DURING THE SARS PANDEMIC AND THAT COVID-19 IS IN THAT SARS FAMILY OF VIRUSES.


There are a number of possibilities with regard to future combinations of antivirals and of antivirals combined with biotherapeutics including nitazoxanide and therapeutic antibodies, as well as immunomodulators.

Combining antivirals with different mechanisms of action, for example, a polymerase inhibitor‐like favipiravir with a NAI ( neuraminidase inhibitors), would be especially interesting for treating more severe forms of influenza or infections in immunocompromised hosts.

It is clear that medical needs exist for more effective therapies for severe influenza, particularly in those who are hospitalised and in immunocompromised hosts.

Considerable progress has been made in the clinical development of intravenous NAIs and to an increasing extent other novel antivirals and biotherapeutics for influenza management. In addition to optimisation of dosing regimens of existing drugs, combination therapies offer great promise going forward.

Selective immunomodulatory interventions, in conjunction with antivirals to control replication, are another promising area for investigation, but the particular type(s) and timing of intervention need to be based on a better understanding of disease pathogenesis.



Why isn’t there more excitement about this readily available treatment?

One possible reason is that chloroquine is a generic drug to which no pharmaceutical company owns the patent.

Big Pharma’s money and lobbying power will strive to persuade governments – and markets – that the only viable solution to the coronavirus is a vaccine.

But in the short term this simply isn’t true.
Nor is it clear to me that the global economy is going to survive on lockdown for as long as it takes to develop and test that vaccine – which may not even prove effective in any case.









__________________________________


END NOTES:
Data as of 20 March 2020, reported by WHO: 

Grand total worldwide*
266,073 CASES; 11,184 DEATHS 1344

Cases in U.S.*
United States of America 15,219 CASES; 201 DEATHS

*Numbers include both domestic and repatriated cases.


[THE CDC REFUSES TO UPDATE THEIR DATA ON WEEKENDS, DESPITE AMERICA'S NEED TO KNOW.] 

Region of the Americas (NORTH, CENTRAL AND SOUTH) :
18,877 cases, 235 deaths 



CDC U.S. UPDATES

https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html



Lancet study data, full text. 
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(03)00806-5/fulltext



National Institutes of Health study 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978626/#b13








//WW

Tuesday, March 17, 2020

CORONAVIRUS IS STILL UNDER 3% FATAL ACROSS ALL AGE GROUPS. STOP THE PANIC!

Thread by @sagaplague: Here is the report of the WHO-China Joint Mission on Coronavirus Disease ...

THESE TWO GRAPHS SHOW WHAT OUR CDC SHOULD BE DOING, AS CHINA DID, TO BRING COVID-19 TO AN END.

THEY MUST TEST, TEST, TEST SO THEY CAN ISOLATE CARRIERS! 


Thread by @sagaplague: Here is the report of the WHO-China Joint Mission on Coronavirus Disease ...

AS THE FOLLOWING PEER-REVIEWED STUDIES AND W.H.O. DATA SHOW MOST CLEARLY, THE OVERALL DEATH RATE FOR CORONAVIRUS IS INDEED LESS THAN 3%.
IT'S 2.3%, ACTUALLY. 


WHY ISN'T OUR MSM (MAINSTREAM MEDIA) REPORTING THIS AND THE CDC'S OWN FACT THAT THE H1N1 (MAINLY B/VICTORIA STRAIN) FROM OUR ONGOING "NORMAL" FLU SEASON HAS A DEATH RATE OF 7.1%, BORDERING ON THE 7.3% AT WHICH POINT CDC DECLARES AN EPIDEMIC?

[FLU SEASON BEGAN IN OCTOBER, 2019.]

WHY ISN'T ANYONE ASSURING AMERICANS AND THE REST OF THE WORLD THAT COVID-19 IS NOT A MEDICAL APOCALYPSE?

WHY AREN'T THE "EXPERTS" TROTTED OUT BY OUR 'NEWS AGENCIES' TELLING US THAT, GLOBALLY, THERE ARE 183,257 KNOWN CASES OF COVID-19 WITH  7,177 DEATHS GLOBALLY COMPARED TO 36 MILLION CASES OF INFLUENZA IN JUST AMERICA WITH AT LEAST 22,000 DEATHS, INCLUDING 144 CHILDREN HERE
?




WHY ISN'T CDC AND THE MEDIA MENTIONING THAT OUR FLU SEASON IS FAR FROM OVER, THAT WE STILL HAVE WIDESPREAD FLU IN 49 STATES AND THE VIRGIN ISLANDS AND PUERTO RICO, THAT 5 MORE CHILDREN DIED OF FLU JUST LAST WEEK? 

WHY HASN'T CDC UPDATED THEIR 'WEEKLY FLU REPORT' SINCE MARCH 7, 2020?


WHY CREATE PANIC OVER COVID-19 YET IGNORE THE ALARMING STATISTICS ON INFLUENZA? 


CHINA HAS A GRIP ON THEIR COVID-19 OUTBREAK. 

Based on all 72,314 cases of COVID-19 confirmed, suspected, and asymptomatic cases in China as of February 11, a paper by the Chinese CCDC released on February 17 and published in the Chinese Journal of Epidemiology has found that:

-- 80.9% of infections are mild (with flu-like symptoms) and can recover at home.

-- 13.8% are severe, developing severe diseases including pneumonia and shortness of breath.

-- 4.7% as critical and can include: respiratory failure, septic shock, and multi-organ failure.


-- In about 2% of reported cases the virus is fatal..

"In China overall, the severe or critical cases among health workers also DECLINED—from 45.0% in early January to 8.7% in early February.

In light of this rapid spread, it is fortunate that COVID-19 has been mild for 81% of patients and has a very low overall case fatality rate of 2.3%.

Among the 1,023 deaths, a majority have been ≥60 years of age and/or have had pre-existing, comorbid conditions such as hypertension, cardiovascular disease, and diabetes. Moreover, the case fatality rate is unsurprisingly highest among critical cases at 49%, and no deaths have occurred among those with mild or even severe symptoms."

SEE ESPECIALLY   
TABLE 1. Patients, deaths, and case fatality rates, as well as observed time and mortality for n=44,672 confirmed COVID-19 cases in Mainland China as of February 11, 2020.

Risk of death increases the older you are.

Relatively few cases are seen among children.



Pre-existing illnesses that put patients at higher risk:

COVID-19 Fatality Rate by COMORBIDITY:

*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%).
This probability differs depending on pre-existing condition.

The percentage shown below does NOT represent the share of deaths BY pre-existing condition.
Rather, it represents, for a patient with a given pre-existing condition, the risk of dying IF infected by COVID-19.

-- cardiovascular disease - 13.2% 
-- diabetes  - 9.2%

-- chronic respiratory disease  - 8.0%

-- hypertension  - 8.4%
-- cancer  - 7.6%

-- NO pre-existing conditions  - 0.9% 



COVID-19 Fatality Rate by AGE:

*Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%). This probability differs depending on the age group. The percentages shown below do not have to add up to 100%, as they do NOT represent share of deaths by age group. Rather, it represents, for a person in a given age group, the risk of dying if, IF infected with COVID-19.  
AGE
DEATH RATE
confirmed cases
DEATH RATE
all cases
80+ years old
21.9%
14.8%
70-79 years old
8.0%
60-69 years old
3.6%
50-59 years old
1.3%
40-49 years old
0.4%
30-39 years old
0.2%
20-29 years old
0.2%
10-19 years old
0.2%
0-9 years old
no fatalities

As you can see, the rate remains very low up to ages 60-69

In general, relatively few cases are seen among children.

Findings from the Huang et al study published on The Lancet: 

COMMON SYMPTOMS
AT ONSET OF ILLNESS
(Huang et al study) 
Fever
98%
Cough
76%
Myalgia (muscle pain)
or Fatigue
44%
LESS COMMON SYMPTOMS:
Sputum production
(coughing up material)
28%
Headache
8%
Haemoptysis(coughing up blood)
5%
Diarrhea
3%


Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
[THIS IS A 40-PAGE PDF COMPILED/MADE PUBLIC 16-24 February 2020.]

The major findings are described in six sections: the virus, the outbreak, transmission dynamics, disease progression and severity, the China response and knowledge gaps. More detailed descriptions of technical findings are provided in Annex C.

Early cases identified in Wuhan are believed to be have acquired infection from a zoonotic source as many reported visiting or working in the Huanan Wholesale Seafood Market.
As of 25 February, an animal source has NOT yet been identified.

  In China, human-to-human transmission of the COVID-19 virus is largely occurring in families.

The Joint Mission received detailed information from the investigation of clusters and some household transmission studies, which are ongoing in a number of Provinces.

Among 344 clusters involving 1308 cases (out of a total 1836 cases reported) in Guangdong Province and Sichuan Province, most clusters (78%-85%) have occurred in families.
Household transmission studies are currently underway, but preliminary studies ongoing in Guangdong estimate the secondary attack rate in households ranges from 3-10%. 

Transmission in closed settings
There have been reports of COVID-19 transmission in prisons (Hubei, Shandong, and Zhejiang, China), hospitals (as above) and in a long-term living facility.

The close proximity and contact among people in these settings and the potential for environmental contamination are important factors, which could amplify transmission. Transmission in these settings warrants further study."
WITH THAT IN MIND, IS IT REALLY A GOOD IDEA TO FORCE PEOPLE TO "SHELTER IN PLACE"? 

PROBABLY NOT, RIGHT?  

SINCE CHINA IS AWARE OF THIS FACTOR, WHY ISN'T OUR CDC ALSO AWARE?
OR ARE THEY AWARE AND STILL NOT TESTING ENOUGH ON PURPOSE? 



I HAD TO TAKE MY OLDER DOG COMPANION TO THE VETERINARIAN YESTERDAY AND WAS TOLD THAT THE CLINIC HAD SUSPENDED IN-ROOM CONSULTATIONS SO THAT WE COULD VISIT WITH OUR VET IN THE MUCH LARGER WAITING ROOM WITH MORE DISTANCE BETWEEN US...AND IT MADE PERFECT SENSE. 
I NOTICED STAFF WIPING DOWN SURFACES (INCLUDING DOOR HANDLES) ALMOST INCESSANTLY. 

THEY WEREN'T GLOVED OR MASKED, HOWEVER, BUT BOTTLES OF HAND SANITIZER WERE EVERYWHERE. 

GOOD NEWS FROM THE WHO/CHINA STUDY

"Children-
Data on individuals aged 18 years old and under suggest that there is a relatively low attack rate in this age group (2.4% of all reported cases).

Within Wuhan, among testing of ILI samples, no children were positive in November and December of 2019 and in the first two weeks of January 2020."


WHAT CHANGED?
SCHOOLS CLOSED, CHILDREN WERE AT HOME IN A CLOSE FAMILY ENVIRONMENT WITH UNTESTED BUT INFECTED PARENTS?


"Symptoms of COVID-19 are non-specific and the disease presentation can range from no symptoms (asymptomatic) to severe pneumonia and death."

THAT'S WHY MASS TESTING SHOULD BE ABSOLUTELY MANDATORY.
SOMEBODY TELL THE CDC! 


TEST MORE IN ORDER TO LOCATE "CHAINS OF INFECTION" AND STOP THEM. 

"Using available preliminary data, the median time from onset to clinical recovery for mild cases is approximately 2 weeks and is 3-6 weeks for patients with severe or critical disease.
Preliminary data suggests that the time period from onset to the development of severe disease, including hypoxia, is 1 week.

Among patients who have died, the time from symptom onset to outcome ranges from 2-8 weeks. An increasing number of patients have recovered; as of 20 February


WHY DON'T MAINSTREAM MEDIA REPORT THIS INSTEAD OF FEAR-MONGERING THE MASSES INTO PANIC?

"China’s bold approach to contain the rapid spread of this new respiratory pathogen has changed the course of a rapidly escalating and deadly epidemic.

A particularly compelling statistic is that on the first day of the advance team’s work there were 2478 newly confirmed cases of COVID-19 reported in China.

Two weeks later, on the final day of this Mission, China reported 409 newly confirmed cases.

This decline in COVID-19 cases across China is real." 


I WISH THE CDC HAD PAID HEED TO THIS HERE IN AMERICA! 

"Much of the global community is not yet ready, in mindset and materially, to implement the measures that have been employed to contain COVID-19 in China.

These are the only measures that are currently proven to interrupt or minimize transmission chains in humans.

Fundamental to these measures is extremely proactive surveillance to immediately detect cases, very rapid diagnosis and immediate case isolation, rigorous tracking and quarantine of close contacts, and an exceptionally high degree of population understanding and acceptance of these measures.

Achieving the high quality of implementation needed to be successful with such measures requires an unusual and unprecedented speed of decision-making by top leaders, operational thoroughness by public health systems, and engagement of society." 



For countries with imported cases and/or outbreaks of COVID-19 1.

1. Immediately activate the highest level of national Response Management protocols to ensure the all-of-government and all-of-society approach needed to contain COVID-19 with non-pharmaceutical public health measures;

2. Prioritize active, exhaustive case finding and immediate testing and isolation, painstaking contact tracing and rigorous quarantine of close contacts;

3. Fully educate the general public on the seriousness of COVID-19 and their role in preventing its spread;

4. Immediately expand surveillance to detect COVID-19 transmission chains, by testing all patients with atypical pneumonias, conducting screening in some patients with upper respiratory illnesses and/or recent COVID-19 exposure, and adding testing for the COVID-19 virus to existing surveillance systems (e.g. systems for influenza-like-illness and SARI); and

5. Conduct multi-sector scenario planning and simulations for the deployment of even more stringent measures to interrupt transmission chains as needed (e.g. the suspension of large-scale gatherings and the closure of schools and workplaces).


IT WORKED FOR CHINA AND SOUTH KOREA, BOTH NATIONS NOW SEEING DECLINE IN NEW CASES, BOTH NATIONS NOW SEEING FAR MORE RECOVERIES THAN NEW CASES. 

IF OUR CDC CAN MANAGE TO FIND A WAY TO IMPLEMENT WHAT THEY KNOW ARE BEST RESPONSES, INCLUDING MASS TESTING, WE CAN SEE AN END TO THIS THING, AND BY NEXT YEAR'S FLU SEASON MAYBE, JUST MAYBE, AMERICANS WON'T BE SO EASILY PANICKED AND RISK SEEING MARTIAL LAW DECLARED TO CONTAIN, NOT THE VIRUS, BUT HYSTERIA





__________________________________

STAY UP-TO-DATE ON BTH CORONAVIRUS AND H1N1 FLU SEASON WITH THE FOLLOWING LINKS:

COVID-19 Coronavirus - Update



Weekly U.S. Influenza Surveillance Report







//WW

Saturday, March 14, 2020

CDC BUSTED FOR FAILING TO TEST.. ONLY 1,895 PEOPLE TESTED FOR COVID-19 FIRST 3 MONTHS. WHY?

FIRST SOME GOOD NEWS: BOTH CHINA AND SOUTH KOREA REPORT A SHARP DECLINE IN NEW CASES AND A RISE IN RECOVERED CASES.

UPI REPORTED THIS GOOD NEWS ABOUT CHINA ON MARCH 9. 


AP REPORTED ON SOUTH KOREA'S DECLINE TODAY. 

WHY ISN'T U.S. MAINSTREAM MEDIA REJOICING WITH BOLD-TYPE HEADLINES?



Above is a photo an emergency room patient in Hawaii took of the assessment of his visit to E.R., noting that he met all but ONE of the FIVE criteria CDC demands be met before they test anyone for COVID-19.

According to U.S. Rep. Tulsi Gabbard (Hawaii), "He was told that because he doesn't have a fever, even though he's been exposed and is sick and has traveled to identified countries, he doesn't meet the criteria to get tested. His elderly mother in law and 5 children live in his house and are at risk if he's positive."

And that is one way you spread a virus, America. REFUSE to test people for it. 
North Carolina has 300 test kits and 100 counties. The state gave three to Mecklenburg County, a county with a population of a million or so people.

CORONAVIRUS CASES TESTED IN U.S. REMOVED FROM CDC WEBSITE, ACCORDING TO CONGRESSMAN: 'AMERICAN PEOPLE DESERVE ANSWERS.'
NEWSWEEK: 

"This is unacceptable.I just sent a letter to
@CDCDirector demanding answers to why their website removed public data on the number of patients tested in the United States. The American people deserve answers."

"Inexplicably, today (MAR.2, 2020), the CDC's public webpage dedicated to COVID-19 data no longer displays how many persons have been tested for, or who have died from COVID-19. I would like to know why," Mark Pocan, who serves Wisconsin's Second District, wrote to director of the CDC Dr. Robert Redfield on Monday.  

BELOW IS A SCREENSHOT OF THE CDC PAGE ON MARCH 1 AND ON MARCH 2. YOU CAN SEE THE DIFFERENCE 


Sanjaya Senanayake, professor of infectious diseases at the Australian National University told Newsweek: "The stopping of publishing those figures is surprising, but perhaps there is a good reason for it."

"During an outbreak of this scale where the general populace is worried, it is really important for governments to make the people feel that they are being kept abreast of various aspects of the outbreak, especially pertaining to their own country. So it is a good idea for a government to give as much information as it feels it responsibly can."

Senanayake added: "This will help maintain a trusting relationship with the public which will be very important if the outbreak gets worse, so as to minimize panic while keeping the public informed with information that they feel is reliable."  The CDC did not immediately respond to a request for comment from Newsweek."

Coronavirus update: Italian tourist in Rajasthan tests positive for COVID-19

AMERICA IS NOT TESTING FOR COVID-19 AS IT SHOULD.
WHY NOT?

FEWER THAN 2,000 ACTUAL COMPLETED TESTS WERE FOUND BY 'THE ATLANTIC', LESS THAN HALF WERE PERFORMED BY CDC.

ALL STATES ARE REPORTING A LACK OF TESTING AND ARE COMPLAINING OF THE CDC RESTRICTIONS ON WHOM CAN BE TESTED.
IT'S NO WAY TO STOP THIS VIRUS!

Alex Michael Azar II, the United States Secretary of Health and Human Services, told ABC News Sunday, March 1, 2020 that  there are 75,000 virus test kits in the United States, but that number will "radically" increase in the next couple of weeks.

STEPHANOPOULOS: Is it time for -- for broader surveillance, testing in communities, taking in people who may not be showing symptoms?

AZAR: Well, right now it's important that we test people who have any type of respiratory illness -- respiratory symptoms that is unidentified. And that's why we -- we, a week ago had -- or actually a week-and-a-half ago expanded to six key cities -- Seattle, San Francisco, L.A., Honolulu, Chicago, and New York -- that if anyone's tested for flu, they also will be tested for novel coronavirus. That is a key part of our emergency supplementals.

THAT'S SIMPLY NOT TRUE, AS PRESIDENTIAL CANDIDATE  AND CURRENT U.S. REPRESENTATIVE FROM HAWAII TULSI GABBARD POINTED OUT. 
"My friend is sick, has had contact with someone who tested positive for
COVID-19.
He's at Urgent Care Hawaii to get tested & was rejected, saying he doesn't
meet the criteria. In the hour he's been there, three other sick people
were turned away,"
Gabbard tweeted on Friday afternoon, MARCH 13, 2020.
In her post, she tagged the social media accounts for the Hawaii government, the
Centers for Disease Control and Prevention (CDC), and the Food and Drug
Administration (FDA).
She also ended the tweet by seemingly asking Hawaii Governor David Ige for an
explanation, writing: "Gov. Ige??"
FDA MANAGED TO STEP IN AND HELP CDC LOCATE MORE AND BETTER TEST KITS. The Food and Drug Administration also has expanded access to private, commercially-manufactured tests so hospitals and doctors can more quickly access tests.

Because these tests are authorized by the FDA, the CDC does not confirm positive results from these commercial tests.

THAT'S LUDICROUS THAT CDC WON'T CONFIRM ANY TEST RESULTS NOT USING THE CDC's VERY OWN KIT! 

WHY WOULD CDC DO THAT?


A COMPANY HERE IN THE U.S. MANUFACTURES RAPID RESULTS KITS AND EXPORTS THEM GLOBALLY. 

"A Cincinnati company’s stock price skyrockets on news of Coronavirus outbreak."
     

THIS WAS ON JANUARY 28, 2020...A READY-TO-GO, MADE IN AMERICA, QUICK LAB TEST HAS BEEN AROUND FOR A FEW YEARS NOW, BUT CDC CHOSE TO DEVELOP ITS OWN, WHICH WAS FLAWED?

"The stock price of Newtown-based Meridian Bioscience was up 40 percent at one point in public trading Monday.

The reason? A product called Lyo-Ready 1-Step RtaPCR Mix.

In layman’s terms, the mix is a screening kit for Coronavirus. But it’s not just that — it’s a screening kit that’s faster and cheaper than most of its competitors.

Meridian China General Manager Liang Zhang, MD, said in the release. “This means that patients can be screened very quickly to help stop the spread of this virus.”

What does that mean? Zhang continues, it means patients can be screened quickly, which in turn can slow the spread of the disease.

On Thursday, March 5th, Vice President Mike Pence said the U.S. did not have enough tests "to meet what we anticipate will be the demand going forward."

For those that we believe have been exposed, for those who are showing symptoms, we’ve been able to provide the testing,” Pence said, adding that there’s roughly about a million and a half tests currently going out to hospitals. 

Sen. Patty Murray (D-Wash.) asked for an explanation as to why the U.S. is not using a World Health Organization (WHO) test and an estimate on how many patients will be able to receive testing in the near future.

The senator’s state of Washington has been hit hardest by the outbreak in the U.S. At least 10 deaths have been reported in the Seattle area, with at least 70 others infected.
Murray also leads the Senate health committee.


WHAT ABOUT THE IN-HOME, RAPID RESULTS TEST KIT NOW BEING OFFERED BY CHINA ? 

Coronavirus Rapid Test Kit China
Item number: 35797
Coronavirus Instant Test Kit available.
Results shows up within 20 minutes.
Suitable for Hospitals, Airport, and Company uses.



Quantity available 10.000.000 (10 million test kits).
Each kit contains its separate buffer, 5 items in each kit.
Price take all: 4.55$ shipped to airport.
Lead Time: Up to 20 Days.
All Certificates are available.
Air Shipping
Shipped from China
Price: 4.55 $

COVID-19 Coronavirus - Update: Last updated: 2020-03-14


WHAT IF TENS OF THOUSANDS OF AMERICANS TESTED POSITIVE FOR COVID-19 AND YET FEW DIED IN COMPARISON?

THAT WOULD END THE GLOBAL PANIC, WOULDN'T IT?

WHAT IF THERE WAS 19 TIMES THE NUMBER OF PEOPLE INFECTED BUT STILL LOW DEATH RATES?

THE FACT THAT CDC STOPPED PUBLISHING THE NUMBER OF NEGATIVE TESTS, THAT CDC REFUSES TO SHARE THE STATISTICS FROM U.S. STATES PUBLICLY SIGNIFIES THAT, JUST LIKE ZIKA, THE DANGER OF DYING FROM CORONAVIRUS IS QUITE LOW.

INITIAL CDC ESTIMATES PUT THE RISK AT BETWEEN 0.01% AND 1%, GLOBALLY. THAT'S NOW SUDDENLY GROWN TO 3.4%.

OF ALL NEWS MEDIA, THE ATLANTIC FINALLY FIGURED THIS OUT...ALMOST...AND DID SOME GOOD INVESTIGATIVE JOURNALISM THAT EXPOSES THE CDC AS AN AGENCY ENGAGED IN YET ANOTHER FEAR-MONGERING FRAUD.

BY DIVING DEEPER INTO THE SCENARIO OF "PANDEMIC", THE ATLANTIC UNWITTINGLY ALSO EXPOSED MAINSTREAM MEDIA AS A COMPANION IN MISINFORMATION CRIME TO KEEP THE FACTS OUT OF THEIR MAINSTREAM HYPE.

AMERICA NOW HAS ABOUT A MILLION COVID-19 TEST KITS BUT DAMNED FEW ARE BEING TESTED.
WHY?

Some coronavirus test kits shipped to states are not working as expected, the CDC says - KRDO

"The COVID-19 test kit could have been in use earlier if the CDC had used one initially developed by the World Health Organization. Instead, the CDC raced to develop its own. (SO THE CDC COULD CONTROL RESULTS?) 


The CDC initially chose to develop its own test based on genetic sequencing of the coronavirus initially reported by scientists in China, where the outbreak was first detected. The test measured tiny DNA samples to confirm whether a person is infected with novel coronavirus, or COVID-19. But soon after the tests were shipped in early February, states had trouble validating one of three components in the CDC’s test kits. States could not confirm the test results. The flaw delayed rapid testing among state and local labs, just as the deadly respiratory virus gained a foothold among infected travelers returning to the United States.

The CDC reviewed the glitch and concluded using two components could accurately detect coronavirus. The CDC began making kits with two components and sharing those kits with states and local public health laboratories." 



STOCKS FOR TEST KITS HAVE SKYROCKETED AND THE KITS WERE ALREADY AVAILABLE FROM A U.S. MANUFACTURER! 

CDC RECENTLY CONFIRMED JUST OVER 500 TESTS PERFORMED N U.S. CITIZENS, WHILE THE ATLANTIC CONFIRMED 1,875.

WHY SO FEW? 

BECAUSE BOTH NEGATIVE TESTS AND POSITIVE TESTS WOULD SHOW CLEARLY THAT THE DEATH RATE FOR CORONAVIRUS IS NO WORSE THAN FOR COMMON FLU, SOMETHING THAT WAS INITIALLY STATED IN LEADING NEWS MEDIA AROUND THE WORLD?

LET'S LOOK AT WHAT THE ATLANTIC HAS EXPOSED.

AS OF THIS WEEK, THERE WERE ABOUT 128,000 CASES OF CORONAVIRUS REPORTED WORLDWIDE.
THOSE WERE ALL DIAGNOSED BY POSITIVE TESTS.

GLOBAL DEATH TOLL FOR THOSE WHO WERE DIAGNOSED WITH COVID-19 IS NEARING 4,700.

SURE, THAT LOOKS WORSE THAN NORMAL FLU, BUT IS IT?
NO!

NO, BECAUSE, FOR WHATEVER REASON, THE U.S. AND OTHER NATIONS ARE NOT TESTING BROADLY.
IN MANY CASES, EVEN THOSE WITH "MODERATE SYMPTOMS" ARE NOT GETTING THE TEST UNLESS THEY GO T HOSPITALS AND SOMETIMES NOT EVEN THEN!
 

“The CDC got this right with H1N1 and Zika, and produced huge quantities of test kits that went around the country,” Thomas Frieden, the director of the CDC from 2009 to 2017, told us. “I don’t know what went wrong this time.”

NOTHING WENT WRONG; IT'S JUST THAT CDC WANTED A PANDEMIC AND NOW WE HAVE  ONE.
CDC AND W.H.O. HAVE DONE THIS SEVERAL TIMES IN THE PAST.

SEE FOR EXAMPLE:

Why Zika Is This Year's Scary Virus BY NATIONAL GEOGRAPHIC. 

The Zika Fraud Is Just Another Pharma Scare   


THEN THERE WAS THE "HORRIBLE" SWINE FLU SCARE, AND NOW THAT SAME H1N1 IS CONSIDERED OUR "NORMAL FLU STRAIN" AND NO MORE PANIC.

UK MEDIA WAS CHARGED WITH OVER-HYPE ON THAT ONE.

"Dr. Wolfgang Wodarg, head of health at the Council of Europe, accused the makers of flu drugs and vaccines of influencing the World Health Organisation's decision to declare a pandemic.

The 'atmosphere of panic' led to governments stockpiling the anti-flu drug Tamiflu and putting in place 'sleeping contracts' for millions of doses of vaccine.

Dr Wodarg said: 'The governments have sealed contracts with vaccine producers where they secure orders in advance and take upon themselves almost all the responsibility.

'In this way the producers of vaccines are sure of enormous gains without having any financial risks.

'So they just wait, until WHO says "pandemic" and activate the contracts.'

AND THE AVIAN FLU, REMEMBER THAT SCARE?

The case of “the impending pandemic of the Avian Flu” might as well have been a fictional mini-series made for television, but as usual, reality is stranger than fiction. It would be hard to make up a story as filled with greed and political corruption as this one.


IF THE CDC TESTED HUNDREDS OF THOUSANDS OR MILLIONS OF AMERICANS AND FOUND TENS OF THOUSANDS POSITIVE RESULTS, BUT ONLY A RELATIVE HANDFUL DIED, THERE'D BE NO SCARY, HYSTERICAL PANDEMIC HEADLINES. 


THE ATLANTIC ARTICLE: 

"Normally, the job of gathering these types of data in the U.S. would be left to epidemiologists at the CDC. The agency regularly collects and publishes positive and negative test results for several pathogens, including multiple types of the seasonal flu. But earlier this week, the agency announced that it would stop publishing negative results for the coronavirus, an extraordinary step that essentially keeps Americans from knowing how many people have been tested overall. 

Then, last night, the CDC resumed reporting the number of tests that the agency itself has completed, but did not include testing by state public-health departments or other laboratories. Asked to respond to our own tally and reporting, the CDC directed us to Messonnier’s statement from Tuesday.

Our reporting found that disorder has followed the CDC’s decision not to publish state data. Messonnier’s statement itself implies that, as highly populous states like California increase their own testing, the number of people the CDC reports as having been tested and the actual number of people tested will become ever more divergent.

The federal tally of positive cases is now also badly out of date.


Our reporting found that the capacity to test for the coronavirus varies dramatically—and sometimes dangerously—from state to state.

California claims the highest testing capacity of any state, and has tested the most individuals so far. As of yesterday afternoon, it had tested 516 people, with 53 positive cases, a spokesperson for the Department of Health told us. The department now has the capacity to test 6,000 people every day, and it expects that capacity to expand to 7,400 people a day starting today, the spokesperson said.

Washington State, the site of the country’s largest outbreak thus far, can test roughly 1,000 people a day. The state health department’s laboratory can test 100 people a day; the rest of the testing is being done at the University of Washington’s Virology Lab. Officials have found 70 positive cases in Washington so far, though a genetic study has estimated that there may be hundreds of untested people who have COVID-19 in the greater Seattle area.

Oregon, situated between the California and Washington hot spots, can test only about 40 people a day. Texas has 16 positive cases, according to media reports, but the health department’s website still lists only three cases. The Texas Tribune has reported that the state can test approximately 30 people a day.

Other states can test even fewer. Hawaii can test fewer than 20 people a day, though it could double that number in an emergency, an official told us. Iowa has supplies to test about 500 patients a day. Arkansas, though not near a current known outbreak, is able to test only four or five patients a day.

New York can test 100 to 200 people a day. Neighboring New Jersey and Connecticut have not shared any information about how many tests they have run, or about their daily testing capacity.

Pennsylvania can test only about a dozen people a day, and Delaware can test about 50 people, our survey found. An official in Massachusetts, where two of 20 tests have come back positive, said that she did not know the Bay State’s daily capacity, but that its health department “currently [has] an adequate supply of test kits.”

Currently, most labs require two specimens to test one person. Single-specimen testing capability is being developed, but right now the top-line number of available tests should be cut in half. In other words, “1.5 million tests” should be able to test roughly 750,000 people.

Some states, such as Colorado, told us how many specimens they could test a day (160), not how many patients (about 80). Other states shared the number of patients they could test, but not the number of specimens.

Through interviews with dozens of public-health officials and a survey of local data from
across the country, The Atlantic could only verify that 1,895 people have been tested for the coronavirus in the United States, about 10 percent of whom have tested positive. And while the American capacity to test for the coronavirus has ramped up significantly over the past few days, local officials can still test only several thousand people a day, not the tens or hundreds of thousands indicated by the White House’s promises.

LET'S LOOK AT THAT.
THE TESTING CAPABILITY IS CURRENTLY AT "SEVERAL THOUSAND PER DAY", PER DAY, BUT ONLY 1,875 HAVE BEEN TESTED IN 3 MONTHS?
WHAT'S WRONG WITH THIS PICTURE?

THE WHITE HOUSE CAN NEITHER FORCE TESTING NOR FORCE RELEASE OF RESULTS TO THE PUBLIC, CAN IT?
IF IT CAN, MAYBE THAT'S EXACTLY WHAT TRUMP SHOULD DO.

ONLY 1,895 PEOPLE TESTED IN AMERICA.
1,201 CASES REPORTED IN AMERICA AS OF TODAY, MARCH 13-14, 2020.


Of those cases in the U.S. (pictured above), at least 48 were diagnosed in individuals who were repatriated to the United States on government charter flights from Wuhan, China, and from the Diamond Princess cruise ship.

33 HAVE DIED:
 MOSTLY ELDERLY WHERE AN "OUTBREAK" IN ONE WASHINGTON STATE NURSING HOME IS UNDER INVESTIGATION.
MOST OF THESE ELDERLY HAD OTHER PRE-EXISTING CONDITIONS THAT MADE THEM MORE SUSCEPTIBLE TO SUCCUMBING TO ANY VIRUS.

Despite the growing number of lab-confirmed COVID-19 cases in the U.S., the figures pale in comparison, for instance, to the seasonal flu, which kills an estimated 12,000 to 61,000 people per year and affects between 9 million and 45 million people in this country alone, according to the Centers for Disease Control and Prevention (CDC).

WHY DID THE CDC STOP REPORTING RESULTS? 

THE ATLANTIC: "Throughout February, the CDC published a regular tally of Americans who had been tested for the pathogen. Last Saturday, several days after the country’s first case of community transmission was confirmed, that figure was 472.

Then the agency stopped updating the tally. It did not publish new numbers of how many Americans had been tested for the virus on Sunday or Monday, as public criticism of the sluggish response to the disease began to mount. On Tuesday, it announced that it would stop publishing the figure altogether.

Our reporting has found that the CDC has not made good on Messonnier’s assurance that state numbers would be available and up to date."


As of March 13 2020, 32,771 people have been tested in the UK, of which 31,973 were confirmed negative and 798 were confirmed as positive.
  Ten patients in the UK who tested positive for COVID-19 have died, all of them were aged over 60 and had underlying health issues.

The worst European outbreak is currently in Italy, where more than 15,000 people have been diagnosed and 1,016 have died. The  severity of the country's outbreak means it has been put into lockdown.


BUT THE U.S. HAS TESTED FEWER THAN 2,000!
DOESN'T MAKE SENSE, DOES IT? 


Check your state's health department for the latest COVID-19 cases by using the links found <HERE>.

Read CDC's FAQ and  instructions for testing <HERE>.

AN EXAMPLE:

Q:
"Should I be testing all patients for COVID-19?

A: Clinicians should base their decisions on whether a patient should be tested for COVID-19 on:
-Signs and symptoms,
-Local epidemiology, and
-If the patient has had close contact with a confirmed COVID-19 patient or a history of travel from an area with sustained transmission within 14 days of symptom onset.

WHY NOT JUST TEST ANY WHO SEE A DOCTOR AND HAVE SYMPTOMS , TEST THOSE WHO WANT TO BE TESTED AFTER POSSIBLE EXPOSURE?

TOO LOGICAL?
OR TOO REVEALING?


HAVE A LOOK AT THIS QUESTION:

How can my lab get the virus?


The National Institute of Health (NIH)’s Biodefense and Emerging Infections Research Resources Repositoryexternal icon (BEI Resources) will provide laboratories with COVID-19.

THOSE ARE THE GUYS WHO SEARCH THE WORLD FOR NEW, ANCIENT, DEADLIER VIRUSES THAN OUR ENEMIES MAY HAVE, FOR OUR, UMMM, "DEFENSE".

THIS IS FROM THE ABOVE-LINKED WEBSITE:

"Who Can Use This Resource?

Users, domestic or foreign, must be a principal investigator, laboratory director, or equivalent in a public or academic institution, or a director of research or equivalent in a private or for-profit institution
Users must work in an established institution with appropriate facilities and safety programs for the appropriate level of registration requested
Users need not be a grantee of NIAID or another National Institutes of Health Institute or Center
There is no charge for the materials (shipping and handling fees may apply).

How To Get Started.

Register to place an order.
Place your order through the online catalog.
All requests by registered users within specified quantity limits are automatically approved by NIAID. Larger amounts may be provided with justification and NIAID approval.

Assurance to Requestors

All information provided to the Contractor will be treated as confidential.
Users will be required to sign a Materials Transfer Agreement, an agreement that governs the exchange of research materials and tools.
Forms are provided for deposits of materials in order to protect the Intellectual Property of the depositor by establishing ownership of the materials and distribution rights.


I believe that I have found a treatment or vaccine for COVID-19. Is CDC the best place to submit my idea?

BARDA is providing a portal to support U.S. government medical countermeasure research and development. Interested stakeholders can learn more here. "

THESE ARE THE SAME GUYS WHO GAVE SADDAM HUSSEIN BIOLOGICAL WEAPONS SAMPLES. 

"A letter written in 1995 by former CDC Director David Satcher to former Senator Donald W. Riegle, Jr., points out that the U.S. Government provided nearly two dozen viral and bacterial samples to Iraqi scientists in 1985--samples that included the plague, botulism, and anthrax, among other deadly diseases. According to the letter from Dr. Satcher to former Senator Donald Riegle, many of the materials were hand carried by an Iraqi scientist to Iraq after he had spent 3 months training in the CDC laboratory.


The American people need the truth. The American people need to know whether the United States is in large part responsible for the very Iraqi weapons of mass destruction which the administration now seeks to destroy. We may very well have created the monster that we seek to eliminate. The Senate deserves to know the whole story. The American people deserve answers to the whole story."  

AS WASHINGTON POST REPORTED:

"The story of U.S. involvement with Saddam Hussein in the years before his 1990 attack on Kuwait -- which included large-scale intelligence sharing, supply of cluster bombs through a Chilean front company, and facilitating Iraq's acquisition of chemical and biological precursors -- is a topical example of the underside of U.S. foreign policy. It is a world in which deals can be struck with dictators, human rights violations sometimes overlooked, and accommodations made with arms proliferators, all on the principle that the "enemy of my enemy is my friend."

SEE ALSO: How Reagan Armed Saddam with Chemical Weapons

"Not only did Ronald Reagan’s Washington turn a blind-eye to the Hussein regime’s repeated use of chemical weapons against Iranian soldiers and Iraq’s Kurdish minority, but the US helped Iraq develop its chemical, biological and nuclear weapons programs."


THESE ARE THE SAME GUYS WHO KEEP "LOSING" SAMPLES, KEEP SENDING SAMPLES TO THE WRONG LABS, KEEP SENDING SAMPLES THROUGH NORMAL  MAIL ROUTES, ETC. 

Lost vials of smallpox found in abandoned NIH closet - UPI

BETHESDA, Md., July 8,2014  (UPI)
-- "Don't worry guys, we found the missing smallpox vials.""According to the NIH, several scientists came upon three vials of smallpox left over from the 1950s.
Though it's been sitting in a storage closet for more than 50 years, experts say the vials could still hold a potent virus.

The CDC says there's no evidence that the stash of variola vials was leaked, and that there is no risk to public health.

Believed to have emerged around 10,000 BCE, the viral disease has killed millions over the course of history. The disease killed roughly half a million Europeans annually during the latter stages of the 18th century. Successful immunization programs eradicated the disease entirely by 1979.

Technically, the vials are in violation of an international bioterrorism law that says only a lab at the CDC's Atlanta headquarters and a lab at the VECTOR Institute in Russia are allowed to host strains of smallpox."


CORONAVIRUS HAS BEEN "STUDIED" IN THE U.S. FOR YEARS.
WE'VE HAD MANY LABS WITH "SAMPLES". 


Scientists were close to a coronavirus vaccine years ago. Then the money dried up.

Dr. Peter Hotez says he made the pitch to anyone who would listen. After years of research, his team of scientists in Texas had helped develop a vaccine to protect against a deadly strain of coronavirus. Now they needed money to begin testing it in humans.

Instead, the SARS vaccine that Hotez's team created in collaboration with scientists at the University of Texas Medical Branch at Galveston is sitting in a freezer, no closer to commercial production than it was four years ago.

"We could have had this ready to go and been testing the vaccine's efficacy at the start of this new outbreak in China," said Hotez, who believes the vaccine could provide cross-protection against the new coronavirus."

ARE YOU BEGINNING TO SEE A PATTERN, AMERICA?
WHY DIDN'T ANYONE WANT A CORONAVIRUS VACCINE YEARS AGO?

1- GO OUT AND FIND VIRUSES.
2- WEAPONIZE THEM.
3- SHARE SAMPLES WITH OTHER LABS.
4- OOPS! IT 'ESCAPED' OR 'SUDDENLY REAPPEARED SOMEWHERE'!
5- WE NEED A VACCINE.
6- MEDIA-HYPE THE LIVING HELL OUT OF IT.
7- GOVERNMENT FUNDING FOR A VACCINE.

RINSE.
REPEAT.


Before President Trump's national emergency declaration, Democrat Rep.
Tulsi Gabbard introduced her own resolution
calling for emergency universal
basic payment in response to the coronavirus pandemic. Her proposal includes
giving $1,000 per month to every American adult to help them "weather the
storm created by this crisis."
"The coronavirus pandemic has created a threat to the health and well-being
of the American people, as well as to our country's economic stability.
While some in Washington are focused on taking care of Wall Street, everyday
Americans get left behind. That's wrong," Gabbard said in a statement."

WHEN THERE IS NOTHING ON THE SHELVES,  NO GASOLINE, NOTHING
NEEDFUL LEFT TO BUY, WHAT GOOD WOULD $10,000 A MONTH DO? 
No milk, no bleach: Americans awake to coronavirus panic buying.

"In Union, New Jersey, a Target opened at 8 a.m. and had sold out of its full stock of milk and bottled water five minutes later.
In Austin, Texas, some gas station pumps ran dry.
Not a bottle of bleach could be found at a Home Depot in Fairfax, Virginia.

As dawn broke across the United States on Saturday, thousands of shoppers lined up outside supermarkets and grocery stores before they opened, eager for a chance to buy essentials that have flown off shelves as the country hunkers down to slow the spread of coronavirus.

“It’s crazy. People have gone crazy,” said Alexis Coppol, a Washington, D.C. resident who was shopping at Costco. “I mean, I’m not too worried, but if we get put on a lockdown I want to make sure I have food.”

Americans have been stocking up on goods for days.

[And toilet paper is now selling on eBay, the only place one can find it for sale, for $4.00- $200.00 PER  ROLL, or 4 rolls for $9.88 PLUS $55.15 shipping.]

IT'S RAMPING UP TO A CHAOTIC GLOBAL PANIC BASED ON MEDIA FEAR-MONGERING, MISINFORMATION, MASS HYSTERIA THAT IS FED DAILY AND WE JUST CAN'T IMAGINE HOW OR WHEN OR IF IT WILL END. 


MARTIAL LAW?
TRUMP HINTED AT THAT JUST TODAY.


MARCH 15, 2020, REUTERS

"U.S. death toll hits 65 from coronavirus, Fed cuts rate, NYC will shutter restaurants, bars, theaters.

With limited testing available, U.S. officials have recorded nearly 3,000 cases and 65 deaths, up from 58 on Saturday. Globally more than 162,000 are infected and over 6,000 have died.

Pence also said the government on Monday morning would issue updated federal guidelines, which he described as “broad-based recommendations for the American public.”Americans are waking up to a new reality as coronavirus spreads, with store shelves stripped bare of essentials, schools closed and millions of jobs in jeopardy as businesses temporarily shut their doors. New York City joined the nation’s other major public school systems in calling off classes starting this week."

THAT'S OUR SITUATION HERE IN AMERICA.

WHEREVER YOU ARE, I HOPE YOU WEATHER THIS SENSELESS STORM.

HOW IT ESCALATED TO THIS POINT GIVEN THAT SO FEW, GLOBALLY, HAVE BEEN INFECTED AND MUCH FEWER HAVE DIED OF COVID-19 THAN IN OUR 'NORMAL FLU SEASON" IS BEYOND MY UNDERSTANDING.

I HOPE YOU ARE ALL WELL AND STAY THAT WAY. 







  _______________________________________

END NOTES: 


--Learn more about the NIAID role in biodefense and emerging infectious disease research.
[

LAST REVIEWED IN 2011? WHY? WHY SO LONG AGO? 



--Early efforts to develop a SARS vaccine in animal trials were plagued by a phenomenon known as "vaccine-induced enhancement," in which recipients exhibit worse symptoms after being injected [with the potential vaccine] — something Dr.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), said researchers must be mindful of as they work to quickly develop a vaccine to protect against COVID-19.

That kind of research — figuring out which vaccine strategies work and which don't — potentially could have been completed before the new outbreak, said Jason Schwartz, a professor at the Yale School of Public Health who studies vaccine development. He said the global response to the coronavirus exposes broader flaws in the way medical research is funded, which he says tends to be market-driven and reactive, rather than proactive.

--WUHAN-400?
Novel predicted China coronavirus outbreak 40 years ago?

The text in the picture reads that the virus was developed at a lab outside of the city of Wuhan, and it was the four-hundredth viable stain [sic] of man-made microorganism at the research center.   

In a strange coincidence, the novel mentions the existence of a research laboratory where the virus Wuhan-400 was developed, and in reality, there is the Wuhan Institute of Virology that studies the deadliest viruses, just 32 km away from the epicenter of current coronavirus outbreak.   


HAD KOONTZ TALKED WITH SOMEONE AT NIH, CDC?

IT'S CRAZY WHAT WE MAY NEVER KNOW, FOLKS. 


-- Arab media: Coronavirus a sinister U.S. plot

"From Ebola, zika, SARS, avian flu and swine flu, through anthrax and mad cow disease to the corona[virus] – [all these] deadly viruses were manufactured by the U.S. and threaten to annihilate the peoples of the world," Hussein Saqer, a columnist for the Syrian daily Al-Thawra wrote.


On the Egyptian news website Vetogate.com, journalist Ahmad Rif'at explained why the U.S. chose the Chinese city of Wuhan as the epicenter of the disease.

"American factories are the first to manufacture every kind of virus and bacteria, from the virulent smallpox virus and the bubonic plague virus to all the viruses we saw in the recent years, such as mad cow disease and swine flu," he wrote.

Rif'at claimed the biological "war is not only intended to worry China, trouble it and cause it to spend billions of dollars on emergency measures and medicines – which, by the way, will be manufactured by an Israeli company."


"The U.S. wants to inform the world, and especially China itself, as part of a propaganda war targeting [China's] prestige and status, that [China] is still a backward country whose citizens eat bat soup and which exports diseases and epidemics to the rest of the world!"WHO KNOWS? 






//WW